The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--<i>ε</i>4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Primer</td><td class="align_center">Sequence</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left" rowspan="2">APOE-<i>ε</i>4</td><td class="align_center">F：5′-TAAGCTTGGCACGGCTGTCCAAGGA-3′</td></tr><tr><td class="align_center">R：5′-ACAGAATTCGCCCCGGCCTGGTACAC-3′</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Contrast Media & Molecular Imaging

tab1

Table 1

Table 1: The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--<i>ε</i>4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia 

Table 1 | The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--ε4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia 